176 related articles for article (PubMed ID: 10673391)
1. Novel functions of human alpha(1)-protease inhibitor after S-nitrosylation: inhibition of cysteine protease and antibacterial activity.
Miyamoto Y; Akaike T; Alam MS; Inoue K; Hamamoto T; Ikebe N; Yoshitake J; Okamoto T; Maeda H
Biochem Biophys Res Commun; 2000 Jan; 267(3):918-23. PubMed ID: 10673391
[TBL] [Abstract][Full Text] [Related]
2. S-nitrosylated human alpha(1)-protease inhibitor.
Miyamoto Y; Akaike T; Maeda H
Biochim Biophys Acta; 2000 Mar; 1477(1-2):90-7. PubMed ID: 10708851
[TBL] [Abstract][Full Text] [Related]
3. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
[TBL] [Abstract][Full Text] [Related]
4. Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition.
Filion ML; Bhakta V; Nguyen LH; Liaw PS; Sheffield WP
Biochemistry; 2004 Nov; 43(46):14864-72. PubMed ID: 15544357
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide inhibits falcipain, the Plasmodium falciparum trophozoite cysteine protease.
Venturini G; Colasanti M; Salvati L; Gradoni L; Ascenzi P
Biochem Biophys Res Commun; 2000 Jan; 267(1):190-3. PubMed ID: 10623597
[TBL] [Abstract][Full Text] [Related]
6. 1-Peptidyl-2-haloacetyl hydrazines as active site directed inhibitors of papain and cathepsin B.
Giordano C; Calabretta R; Gallina C; Consalvi V; Scandurra R
Farmaco; 1991 Dec; 46(12):1497-516. PubMed ID: 1821630
[TBL] [Abstract][Full Text] [Related]
7. Kinetics and stoichiometry of inactivation of some pancreatic and leucocyte serine proteinases by rabbit alpha 1-proteinase inhibitors F and S.
Koj A; Dubin A; Kurdowska A
Biomed Biochim Acta; 1983; 42(10):1221-8. PubMed ID: 6372791
[TBL] [Abstract][Full Text] [Related]
8. Tellurium-based cysteine protease inhibitors: evaluation of novel organotellurium(IV) compounds as inhibitors of human cathepsin B.
Cunha RL; Urano ME; Chagas JR; Almeida PC; Bincoletto C; Tersariol IL; Comasseto JV
Bioorg Med Chem Lett; 2005 Feb; 15(3):755-60. PubMed ID: 15664852
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of 3C protease from human rhinovirus strain 1B by peptidyl bromomethylketonehydrazides.
Kati WM; Sham HL; McCall JO; Montgomery DA; Wang GT; Rosenbrook W; Miesbauer L; Buko A; Norbeck DW
Arch Biochem Biophys; 1999 Feb; 362(2):363-75. PubMed ID: 9989947
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation.
Li J; Billiar TR; Talanian RV; Kim YM
Biochem Biophys Res Commun; 1997 Nov; 240(2):419-24. PubMed ID: 9388494
[TBL] [Abstract][Full Text] [Related]
11. N-[2,2-dimethyl-3-(N-(4-cyanobenzoyl)amino)nonanoyl]-L-phenylalanine ethyl ester as a stable ester-type inhibitor of chymotrypsin-like serine proteases: structural requirements for potent inhibition of alpha-chymotrypsin.
Iijima K; Katada J; Yasuda E; Uno I; Hayashi Y
J Med Chem; 1999 Jan; 42(2):312-23. PubMed ID: 9925737
[TBL] [Abstract][Full Text] [Related]
12. The 1,4-naphthoquinone scaffold in the design of cysteine protease inhibitors.
Valente C; Moreira R; Guedes RC; Iley J; Jaffar M; Douglas KT
Bioorg Med Chem; 2007 Aug; 15(15):5340-50. PubMed ID: 17532221
[TBL] [Abstract][Full Text] [Related]
13. Schistosoma mansoni: isolation and characterization of Smpi56, a novel serine protease inhibitor.
Ghendler Y; Arnon R; Fishelson Z
Exp Parasitol; 1994 Mar; 78(2):121-31. PubMed ID: 8119369
[TBL] [Abstract][Full Text] [Related]
14. S-Nitrosylation of human variant albumin Liprizzi (R410C) confers potent antibacterial and cytoprotective properties.
Ishima Y; Sawa T; Kragh-Hansen U; Miyamoto Y; Matsushita S; Akaike T; Otagiri M
J Pharmacol Exp Ther; 2007 Mar; 320(3):969-77. PubMed ID: 17135341
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of cysteine proteases.
Govardhan CP; Abeles RH
Arch Biochem Biophys; 1996 Jun; 330(1):110-4. PubMed ID: 8651683
[TBL] [Abstract][Full Text] [Related]
16. Proteinase inhibitors from horse plasma and leucocytes: properties and biological functions.
Dubin A; Koj A
Biomed Biochim Acta; 1986; 45(11-12):1391-6. PubMed ID: 3495263
[TBL] [Abstract][Full Text] [Related]
17. Azapeptides as inhibitors and active site titrants for cysteine proteinases.
Xing R; Hanzlik RP
J Med Chem; 1998 Apr; 41(8):1344-51. PubMed ID: 9548822
[TBL] [Abstract][Full Text] [Related]
18. Probing the potential of platinum(II) complexes for the inhibition of thiol-dependent enzymatic activity.
van Zutphen S; Kraus M; Driessen C; van der Marel GA; Overkleeft HS; Reedijk J
J Inorg Biochem; 2005 Jun; 99(6):1384-9. PubMed ID: 15869797
[TBL] [Abstract][Full Text] [Related]
19. Interactions of alpha1-proteinase inhibitor with small ligands of therapeutic potential: binding with retinoic acid.
Karnaukhova E
Amino Acids; 2010 Apr; 38(4):1011-20. PubMed ID: 19495939
[TBL] [Abstract][Full Text] [Related]
20. Interaction of horse plasma antithrombin III and alpha 1-proteinase inhibitor with some serine proteinases.
Koj A; Kurdowska A
Acta Biol Med Ger; 1981; 40(10-11):1561-70. PubMed ID: 6979142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
